News
BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...
The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...
The rapid global march of the coronavirus that began in Wuhan, China several months ago could be slowed by researchers and biotech firms 7,770 miles away – in the Research Triangle of North Carolina.
Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...
Merakris Therapeutics, LLC, a Research Triangle Park regenerative medicine company developing wound-healing products for skin and eyes, has launched a new skin-graft alternative to help protect and ...
There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar ...
Corteva Agriscience, a spinout from Dow/Dupont with two North Carolina locations, said its new seed rebranding will help it serve its customers better. The company, which launched as a separate entity ...
Bryn Pharma, a privately held Raleigh medical device company, is on track to soon provide people who have severe, possibly life-threatening allergies a needle-free option to treat anaphylaxis. The U.S ...
When singer songwriter Joni Mitchell wrote “...you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at ...
This story was published by Duke Health on June 22. KANNAPOLIS, N.C. -- Duke’s MURDOCK Study has launched a COVID-19 research project to follow the health of hundreds of North Carolina volunteers for ...
Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...
Worried that your dog might contract the COVID-19 coronavirus – and what pet owner isn’t these days? Or concerned that your meandering daily dog walks could result in close encounters of the human ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results